Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-069-1 | CAS number: 68002-54-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
In accordance with Annex VIII of the Regulation (EC) 1907/2006 (REACH), an assessment of the toxicokinetic behaviour of the substance (as required in section 8.8.1) is performed to the extent that can be derived for the relevant available information. A toxicokinetic assessment was performed based on the available physical-chemical data and toxicological information available. Further testing for the assessment of toxicokinetic behaviour is omitted on this basis.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 25
- Absorption rate - inhalation (%):
- 100
Additional information
In accordance with Annex VIII of the Regulation (EC) 1907/2006 (REACH), an assessment of the toxicokinetic behaviour of the substance (as required in section 8.8.1) is performed to the extent that can be derived for the relevant available information. A toxicokinetic assessment was performed based on the available physical-chemical data and toxicological information available. Further testing for the assessment of toxicokinetic behaviour is omitted on this basis.
Introduction
The substance is a brown paste and is a UVCB organic substance. No experimental studies of the absorption, metabolism, distribution or elimination of Tall oil, compound with ethanolamine (“the compound”) in mammals are available. However, information is available from existing toxicology studies on the compound, or for other very similar materials, and this data is used to infer, where possible, the potential toxicokinetic properties of the compound.
Physicochemical properties
Systemic availability of the compound depends on its ability to be absorbed across body surfaces. Factors that affect this process include water solubility, lipophilicity (measured by the partition coefficient, Kow), degree of ionisation (the dissociation constant, pKa) and molecular size. Given the large number of components within the compound, it has a molecular weight of 202 to 379 g/mol. It is considered insoluble in water (visually determined as < 1.18 mg/L in purified water at 20 °C). The dissociation constant was not technically feasible. The log Kow ranged from 4.10 to 7.75, with a weight average log10 Kow calculated to be 6.56.
Absorption
Oral absorption
The acute oral LD50 was found to be greater than 2000 mg/kg bw in an OECD 420 oral gavage study, with no clinical signs and no effect on body weight observed. In addition, no gross abnormalities were observed at necropsy. Nothing can be inferred about the nature of oral absorption from this study. In an OECD 422 repeat-dose/reproductive toxicity study, treatment with the compound at levels up to the limit dose of 1000 mg/kg/day was associated with marked toxicity, but limited systemic findings at the top dose suggest that some absorption took place. Because of the insolubility of the compound in water, and high Pow, complete absorption via the oral route is unlikely. In the absence of quantitative information, 50 % bioavailability following oral administration is assumed for the purposes of human risk assessment.
Dermal absorption
No acute dermal toxicity study is available. Skin irritation and sensitisation studies with very similar materials gave no signs that the test material reacted chemically with living layers of the skin or eye. Nothing can be inferred about the dermal penetration properties of the compound from these studies. For the purposes of risk assessment however, estimation of mammalian dermal absorption is made in accordance with principles adopted by the EFSA guidance on estimating dermal absorption of pesticide active substances (EFSA, 2012). On this basis, dermal absorption is estimated at 25 % for undiluted compound.
Inhalation absorption
In the absence of any quantitative data, absorption of the compound is considered to be 100 %.
Distribution, Metabolism and Elimination
No information is available to describe the distribution, metabolism or elimination of the compound, although repeat dose studies indicate at least exposure of the bone marrow.
Conclusion
For the purposes of human risk assessment oral absorption of the substance is estimated at 50 %, inhalation absorption is estimated at 100 % and dermal absorption is estimated at 25 %.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.